Cytosolic 5'-nucleotidase 1A autoimmunity in sporadic inclusion body myositis. - Wikidata - awgldk - TriplyDB

Cytosolic 5'-nucleotidase 1A autoimmunity in sporadic inclusion body myositis.

Cytosolic 5'-nucleotidase 1A autoimmunity in sporadic inclusion body myositis.

http://www.wikidata.org/entity/Q34675925

about

Autoimmune Myopathies: Where Do We Stand?Emerging therapeutic options for sporadic inclusion body myositis Scanning for Therapeutic Targets within the Cytokine Network of Idiopathic Inflammatory Myopathies Update in inclusion body myositis New autoantibody detection technologies yield novel insights into autoimmune disease Diagnosis and classification of idiopathic inflammatory myopathies.Report on the 3rd Ottawa International Conference on Neuromuscular Biology, Disease and Therapy - September 24-26, 2015, Ottawa, Canada.Immunotherapies for Immune-Mediated Myopathies: A Current Perspective Immune and myodegenerative pathomechanisms in inclusion body myositis Sporadic inclusion body myositis: the genetic contributions to the pathogenesis.Inclusion body myositis and chronic lymphocytic leukemia: a case series.Treatment of sporadic inclusion body myositis with bimagrumab Ongoing developments in sporadic inclusion body myositis Sporadic inclusion body myositis: new insights and potential therapy.PhIP-Seq characterization of autoantibodies from patients with multiple sclerosis, type 1 diabetes and rheumatoid arthritis.An overview of polymyositis and dermatomyositis.Discovery of protein interactions using parallel analysis of translated ORFs (PLATO).Targeted sequencing and identification of genetic variants in sporadic inclusion body myositis.Misdiagnosis of inclusion body myositis: two case reports and a retrospective chart review Development of autoantibodies against muscle-specific FHL1 in severe inflammatory myopathies.Disease specificity of autoantibodies to cytosolic 5'-nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseases.Cytosolic 5'-Nucleotidase 1A As a Target of Circulating Autoantibodies in Autoimmune Diseases Development and evaluation of a standardized ELISA for the determination of autoantibodies against cN-1A (Mup44, NT5C1A) in sporadic inclusion body myositis.Diagnosis, pathogenesis and treatment of myositis: recent advances.Muscle disorders: the latest investigations.Inclusion body myositis: from immunopathology and degenerative mechanisms to treatment perspectives.Understanding and applying tyrosine biochemical diversity.Myositis specific and associated autoantibodies in the diagnosis and management of juvenile and adult idiopathic inflammatory myopathies.Amyloid deposits and inflammatory infiltrates in sporadic inclusion body myositis: the inflammatory egg comes before the degenerative chicken.Myositis Mimics.Idiopathic inflammatory myopathies: from immunopathogenesis to new therapeutic targets.An overview of muscle diseases presenting in adulthood.Myositis-specific autoantibodies: an important tool to support diagnosis of myositis.Pathomechanisms of anti-cytosolic 5'-nucleotidase 1A autoantibodies in sporadic inclusion body myositis.Sporadic inclusion body myositis - a myodegenerative disease or an inflammatory myopathy.Diagnostic criteria for inclusion body myositis.Cytosolic 5'-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis.Immune-Array Analysis in Sporadic Inclusion Body Myositis Reveals HLA-DRB1 Amino Acid Heterogeneity Across the Myositis Spectrum.Integrated classification of inflammatory myopathies.Autoimmune Myopathies.

P2860

Q26744554-AFA8D71A-C744-4EAA-B8E6-C1833FB64B09 Q26786571-942CBEF3-5FE6-417C-AD4E-F040E3336CF5 Q26798209-EF3C54A5-CF63-4883-8649-C333D78580E1 Q26829906-F76C8B6E-3492-46E5-A3B3-4EE28BF975FB Q27000173-88A70B2D-F304-4FE1-BBD1-732F2E76CAB3 Q30249522-43CA017F-A2D5-4482-ADEB-1FF6406BAA40 Q30355125-1683393C-714A-422A-BA60-B6179CD638C1 Q30699742-3990B43C-6900-4225-8F9D-A11439CA51FA Q33753870-48CC52EC-7D5C-447C-B0F0-685B58B50EA0 Q33806912-EA4846D1-AC1A-4155-B400-8B9F3D43AEF3 Q33965427-6B53D85D-2773-438F-881F-576D54F2408A Q34446951-AAD673AD-C505-4E2F-9FD9-71CBD636470E Q34519540-D86E4E25-0588-41E6-8D04-81725FCC3989 Q34591787-A341167B-0FB2-4096-97EE-3A5213FF03A7 Q34623840-7EAFAB69-C693-437B-9710-2457AAA93987 Q34667765-8BD31E13-1ECB-443B-BC3A-BFCC2AD1C66A Q35066562-1AE8FD2D-405B-4937-A542-8211A36C2887 Q35213944-D603BA47-382F-4DC1-ACB4-D18EE130EFD4 Q35944757-ACA3A751-F7D9-4577-9128-B08B09FE8C35 Q36335887-CC8F6206-EF9C-400A-818A-1CEB6E4D32C7 Q36424500-3D689B76-5A4F-4434-8854-928C1B80A921 Q36953554-4F29C118-10F8-4B60-9E46-14603CF3B6CF Q37421042-498A29BC-ACE5-4AEA-AE7E-98F4EA402871 Q38131849-8776950A-7976-410D-8533-3BDD34ADBA04 Q38134153-68676B33-A7A4-41CC-8626-C1248E7521F3 Q38153797-E1FA0F74-9B1E-4AD0-907B-05154BBF8B89 Q38195522-1E81DEC3-428D-484B-9EB1-C74A49B0D93B Q38281749-3FB2FB99-601B-4244-BA97-B8B1DC2D0A0E Q38314711-7F144C4A-095A-4BB7-A583-83B3B181F404 Q38569863-63291869-2D61-4A86-A6AD-BCD0958DCAE6 Q38589301-52B0766D-0F0A-4716-9CE4-43457D1E29D5 Q38604929-694494B5-069A-47F3-A505-733D2CAF0B34 Q38646384-CDB335BC-96E3-48CB-9BA7-DDBBBCA70758 Q38711585-65BC3F79-B656-40A7-B36E-F5F2F6F24FBC Q38767200-D92E4C0A-4FF0-4FC8-BDC5-150559F6AC50 Q38793315-7962CDD7-B083-4A8B-A255-07DA9E1F70F2 Q38999120-8F233CDB-61E8-4663-80E0-BD0C85507776 Q39021882-59CA8D42-5528-49FD-BA7B-6A1F7532E53C Q39027323-49484279-C9B5-4D3D-83D5-F0C6C3C42B57 Q39030495-AC64819B-841C-4D65-B4F3-8D1AD78C0AED

P2860

Cytosolic 5'-nucleotidase 1A autoimmunity in sporadic inclusion body myositis.

http://www.wikidata.org/entity/Q34675925

description

2013 nî lūn-bûn

@nan

2013 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի մարտին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Cytosolic 5'-nucleotidase 1A autoimmunity in sporadic inclusion body myositis.

@ast

Cytosolic 5'-nucleotidase 1A autoimmunity in sporadic inclusion body myositis.

@en

Cytosolic 5'-nucleotidase 1A autoimmunity in sporadic inclusion body myositis.

@nl

type

label

Cytosolic 5'-nucleotidase 1A autoimmunity in sporadic inclusion body myositis.

@ast

Cytosolic 5'-nucleotidase 1A autoimmunity in sporadic inclusion body myositis.

@en

Cytosolic 5'-nucleotidase 1A autoimmunity in sporadic inclusion body myositis.

@nl

prefLabel

Cytosolic 5'-nucleotidase 1A autoimmunity in sporadic inclusion body myositis.

@ast

Cytosolic 5'-nucleotidase 1A autoimmunity in sporadic inclusion body myositis.

@en

Cytosolic 5'-nucleotidase 1A autoimmunity in sporadic inclusion body myositis.

@nl

P1433

Q34675925-2FEC5F2E-9E85-46DD-9746-EB0810B941A6

P1476

Q34675925-801FC535-83A2-4AC3-8BC6-B43D0F8EB7F4

P2093

Q34675925-1BF21E29-7151-4F76-9492-352AA3EBBD9B

Q34675925-1C936FA1-422D-4EC0-B3C4-ED1C6D8C373F

Q34675925-433EE7EF-4739-4F77-8975-9BF1A474D9B5

Q34675925-48207EE9-23EE-4B54-B3E0-25E392F86D82

Q34675925-4B2B6971-0EF2-44C4-A4B4-085B94A95BCD

Q34675925-5004C814-9DDD-4D46-AED1-C53DBFF91C42

Q34675925-62D111C6-83EF-4B49-B179-4360FF6BCA3A

Q34675925-67EC08CE-812C-4436-BA70-A193EA5CC398

Q34675925-E66D0C45-906C-4248-9834-BF17E31FD505

Q34675925-ECD2A35D-55ED-4024-AEAA-5920762A1556

P2860

Q34675925-09A2ABBF-0B77-4799-841B-26319C9273B5

Q34675925-11203FB9-2E26-4F29-8B97-603F53F839A2

Q34675925-1A1B1165-02CC-4AB7-9FB1-B793047680A4

Q34675925-232E0AB7-3F7A-4156-BA1D-F246AF4520E6

Q34675925-320F280E-3ABF-4330-B5B8-EC39FB92AA78

Q34675925-360E1836-6D4A-4D3C-8DC8-426D59A1B6A7

Q34675925-37759D39-9FE7-4E9E-AE6E-61CC93D2A904

Q34675925-3C2B745E-F117-47E9-9311-C402A1E87686

Q34675925-444303E7-B12A-40E1-8E30-35AA882BD8E9

Q34675925-4F9944BB-1386-4F8D-9D35-14E4A212418D

P304

Q34675925-50B4B231-55CE-4A05-B193-495F3296214F

P31

Q34675925-92538E39-A275-40DE-9382-CA8171FA65E2

P356

Q34675925-D03F1EA4-1836-4B3F-9DC5-5EA7195B1256

P433

Q34675925-305419C9-32D3-4389-AB39-CA302B601CED

P478

Q34675925-450BAA52-CC9F-4A8A-B613-A5331A02ED4D

P50

Q34675925-191B534F-C5D9-4A85-8F5C-00855020287F

P577

Q34675925-3885A8A6-D698-48C3-87AB-DDD4D2EFB164

P5875

Q34675925-5E9FDC83-E007-4857-AC7B-FCC4150EC3C1

P698

Q34675925-918DC7FC-A05E-4F9C-AEB1-F415E277DB2E

P356

P1433

Annals of Neurology

P1476

Cytosolic 5'-nucleotidase 1A autoimmunity in sporadic inclusion body myositis

@en

P2093

Anthony A Amato

http://www.w3.org/2001/XMLSchema#string

H Benjamin Larman

http://www.w3.org/2001/XMLSchema#string

Hanno Steen

http://www.w3.org/2001/XMLSchema#string

Jack L Pinkus

http://www.w3.org/2001/XMLSchema#string

John Sauld

http://www.w3.org/2001/XMLSchema#string

Mohammad Salajegheh

http://www.w3.org/2001/XMLSchema#string

Remedios Nazareno

http://www.w3.org/2001/XMLSchema#string

Stephen J Elledge

http://www.w3.org/2001/XMLSchema#string

Steven A Greenberg

http://www.w3.org/2001/XMLSchema#string

Theresa Lam

http://www.w3.org/2001/XMLSchema#string

P2860

Human cytosolic 5'-nucleotidase I: characterization and role in nucleoside analog resistance

I-TASSER: a unified platform for automated protein structure and function prediction

Sarcoplasmic redistribution of nuclear TDP-43 in inclusion body myositis

Human genome sequencing using unchained base reads on self-assembling DNA nanoarrays

A local antigen-driven humoral response is present in the inflammatory myopathies.

Permissive environment for B-cell maturation in myositis muscle in the absence of B-cell follicles.

Autoantigen discovery with a synthetic human peptidome.

Autoantibodies against a 43 KDa muscle protein in inclusion body myositis

Theories of the pathogenesis of inclusion body myositis.

Dermatomyositis and polymyositis: Clinical presentation, autoantibodies, and pathogenesis.

P304

408-418

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANA.23840

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

73

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236225287

http://www.w3.org/2001/XMLSchema#string

P698

23596012

http://www.w3.org/2001/XMLSchema#string